Results 71 to 80 of about 7,585 (168)

Relationship of Anti-Desmoglein-3 Antibody Titres by ELISA with ClinicalABSIS Scoring in Pemphigus Vulgaris

open access: yesRGUHS Journal of Medical Sciences
Background Pemphigus vulgaris PV is a severe potentially life-threatening autoimmune blistering disease that is relatively common in India and occurs due to circulating autoantibodies against Desmoglein Dsg3.
Anisha Manocha   +2 more
doaj   +1 more source

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris. [PDF]

open access: yesActa Derm Venereol, 2022
Boch K   +8 more
europepmc   +1 more source

Non-COVID-19 Vaccinations and the Induction of Autoantibodies in Pemphigus Diseases: A Review of the Speculative Issue and Our Clinical-Laboratory Experience

open access: yesAntibodies
Background: Pemphigus diseases are rare autoimmune blistering disorders mediated by pathogenic autoantibodies directed mainly against desmoglein 1 and desmoglein 3.
Maksymilian Markwitz   +4 more
doaj   +1 more source

Rilzabrutinib-induced transition from pemphigus vulgaris to pemphigus foliaceous: case report and review of the literature

open access: yesDermatology Reports
The discovery of the role of Bruton’s Tyrosine Kinase (BTK) in inflammation and autoimmunity has recently led to the development of BTK inhibitors for the treatment of autoimmune diseases, including pemphigus vulgaris.
Christian Ciolfi   +5 more
doaj  

Circulating Antibodies Against DSG1 and DSG3 in Patients with Oral Lichen Planus: A Scoping Review

open access: yesAntibodies
Oral Lichen Planus (OLP) is a chronic autoimmune disease with potential overlap with Pemphigus Vulgaris (PV), particularly in erosive forms. Desmoglein 1 and 3 are transmembrane glycoproteins of desmosomes, typically involved in PV.
Domenico De Falco   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy